Key result
TNF reduced PHEX expression in human osteosarcoma cell lines, an effect that was reversed by a proteasome inhibitor but not significantly by PARP1 inhibition.
Why the study?
The molecular mechanisms underlying loss of bone mineral density in chronic inflammatory diseases, specifically TNF-mediated downregulation of PHEX expression in human osteoblasts, remain poorly understood.
Answers are grounded in this paper and cite their sources.
In human osteoblasts, TNF downregulates PHEX expression via the NF-κB pathway, but unlike in rodents, PARP1 inhibition does not reverse this effect.
Although loss of bone mineral density is a common symptom of chronic inflammatory diseases, its mechanisms are still poorly understood. The PHEX gene encodes a Zn-endopeptidase expressed in osteoblasts and contributes to bone mineralization. Data derived from rodents has indicated co-repression of the PHEX gene by the NF-κB pathway and poly(ADP-ribose) polymerase 1 (PARP1). The aim of this study was to determine the molecular mechanism involved in TNF-mediated downregulation of PHEX expression in human osteoblasts and human osteosarcoma cell line. We observed that activation of the NF-κB pathway by TNF was manifested as a nuclear increase in RELA and NFKB1 heterodimer. We found that TNF reduced PHEX expression and the proteasome inhibitor reversed this effect in osteosarcoma cell line. Contrary to the effects seen in rodents, inhibition of PARP1 enzymatic activity did not significantly reverse the effect of TNF on the human PHEX gene expression. EMSA studies showed that the number of adenines in the PHEX proximal promoter is crucial for the transcription factors' interactions within that region. The obtained results support the hypothesis indicating the existence of a molecular mechanism of gene repression that involves a poly adenine-rich region of the proximal gene promoters and PARP1 transcriptional activity.
No takes yet. Share an insight, caveat, or question.
Majewski et al. (2018) studied Loss of bone mineral density in chronic inflammatory diseases. TNF was evaluated on PHEX gene expression. TNF reduced PHEX expression in human osteosarcoma cell lines, an effect that was reversed by a proteasome inhibitor but not significantly by PARP1 inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: